Irwin Freedberg and the Changing Times of Academic Medicine  by Hellman, Samuel
COMMENTARY
 www.jidonline.org 525
scope and correctly believed that aes-
thetic concerns regarding the skin and 
its diseases should also be included 
to best serve students, practitioners, 
and, most importantly, patients. He 
also strengthened the DIGM “sig-
nature,” the integration of the basic 
and clinical sciences, by soliciting 
from contributors new approaches to 
the biology, structure, and function 
of the skin. Further, he introduced or 
expanded sections on evidence-based 
dermatology, skin changes over the 
lifespan, dermatologic therapy, der-
matologic surgery, and the emerg-
ing types of biologic therapy. At the 
same time, he reduced the roughly 
3,000 pages of the unwieldy fourth 
and fifth editions to 2,600 pages in the 
most recent sixth edition, upgraded 
the illustrative material that now is in 
full color throughout the book, and 
had all diagrams redrawn for ease of 
interpretation. Under Irwin’s leader-
ship, all the chapters on basic science 
were extensively rewritten to reflect 
the enormous advances made during 
the preceding decade. DIGM being a 
classic, Irwin advocated renaming it 
Fitzpatrick’s Dermatology in General 
Medicine to honor Dr Fitzpatrick, who 
had relinquished his role as a senior 
editor by the time of the fifth edition.
During production of the fifth and 
sixth editions, Irwin insisted on proof-
reading each chapter himself and 
reviewing the entire two-volume work 
to eliminate overlaps and redundan-
cies. He was a relentless worker, and 
only his wife Irene knows how much 
time and effort he invested in this 
project. In recognition of his vision 
and ongoing contributions, after Irwin 
relinquished his membership of the 
DIGM editorial board, his co-editors 
(Lowell A. Goldsmith, Stephen I. Katz, 
Barbara A. Gilchrest, Amy S. Paller, 
David J. Leffell, and myself) asked him 
to remain as an advisor for the seventh 
edition, now in preparation, and he 
admirably fulfilled this responsibility 
until his untimely death.
Irwin was a strong-handed edi-
tor whose authority was based on 
personal integrity as well as on the 
breadth and depth of his knowledge. 
A master of both clinical dermatol-
ogy and basic science, always abreast 
of recent developments in the field, 
he himself epitomized DIGM’s high 
standards. Irwin was also a compas-
sionate human being, unfailingly kind 
and understanding, with limitless and 
infectious enthusiasm and a unique 
sense of humor. These characteristics, 
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Irwin and I were fortunate to become 
physicians during the early years of 
the scientific revelations of the “new 
biology” that began to inform academ-
ic medicine. We both were medical 
house officers at Beth Israel Hospital 
in Boston during the latter days of 
Herman Blumgart’s reign as chair 
of medicine. Superb clinical medi-
cine prevailed with great emphasis 
on clinical–pathological correlation, 
infectious disease, and, most impor-
tantly, the observation, quantification, 
and manipulation of human physiol-
ogy. These pursuits were the bedrock 
of academic medicine. But Watson–
Crickery was in the air! At Beth Israel 
Hospital, Blumgart was succeeded by 
Howard Hiatt, recently returned from 
participating in the earliest days of the 
new biology at the Pasteur Institute. 
Hiatt brought a whole new vision of 
academic medicine. Irwin left Beth 
Israel Hospital during the Blumgart 
era to do his dermatology training at 
Massachusetts General Hospital and 
returned to join Hiatt in implementing 
a new paradigm of academic medi-
cine. I too left for my training and a 
junior faculty position at Yale. After I 
returned to Boston, both Irwin and I 
were engaged in building our respec-
tive academic programs in the clinic 
and the laboratory. Not only was Irwin 
building dermatology; under Hiatt’s 
leadership he, H. Richard Nesson, 
Howard Frazier, and others were 
remaking academic medicine at Beth 
Israel.
Irwin had spent the academic year 
1961–1962 as a postdoctoral fellow 
in the biochemistry department at 
Brandeis University and that of 1969–
1970 on a Guggenheim Fellowship 
at the Weizmann Institute in Israel. 
Both of these experiences equipped 
him with the tools of modern molec-
ular science. The titles of two papers 
authored by Irwin and published by 
the New England Journal of Medicine 
capture these two phases of his aca-
demic medical research. The first, 
published in 1957, “The thyroid gland 
in pregnancy,” was the kind of care-
ful observation and quantification of 
human physiology that was character-
istic of the academic medicine of the 
time. Irwin was the first author, and 
his coauthors were Milton Hamolsky 
(later to chair the Department of 
Medicine at Brown University) and 
Irwin’s uncle A. Stone Freedberg, a 
distinguished cardiologist interested in 
the relationship between thyroid func-
tion and the heart. The second paper, 
“Rashes and ribosomes,” authored 
only by Irwin and published just ten 
years later, offered promise of the 
practical relevance of basic molecular 
biology to clinical medicine.
in combination with high energy and 
a passion for perfection, explain the 
level of excellence he achieved. All 
that he accomplished, he did for his 
profession and for us, his extended 
dermatologic family.
Irwin, we will miss you.
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We were bursting with energy and 
enthusiasm for our growing families, 
these medical and scientific enter-
prises, and life in general. Though this 
may not be imaginable today, federal 
funding for research was plentiful. 
Good and not so good ideas were 
funded, and, because funds were 
plentiful, offbeat but imaginative ideas 
could be pursued. Those were heady 
days! Commercial involvements were 
less common, health-care reimburse-
ments were cost-based, and there was 
little competitive pressure among hos-
pitals. In fact, inter-hospital collabora-
tion was encouraged. Irwin developed 
a combined dermatology program for 
some of the Harvard-affiliated hos-
pitals around the Harvard Medical 
School while I developed the Joint 
Center for Radiation Therapy for these 
and other hospitals. These programs 
were collaborative clinical, teaching, 
training, and research enterprises.
Easy funding, cost-based reim-
bursements, and, of course, our 
youth, along with a major saltation 
in science — the new biology — that 
resulted in a Kuhnian paradigm shift, 
made these the best of times. Others 
in this volume will discuss Irwin’s aca-
demic contributions, but suffice it to 
say that he was very successful and 
drew notice. In 1977 Johns Hopkins 
convinced Irwin to resign his Harvard 
professorship in order to become the 
first chairman of their fledgling der-
matology department. He leapt into 
this endeavor with his accustomed 
enthusiasm. Then, in 1981, the oppor-
tunities offered by chairmanship of the 
biggest, most distinguished and well-
financed department of dermatology, 
as well as the allure of New York City, 
attracted Irwin to New York University 
to lead what is now the Ronald O. 
Perelman Department of Dermatology 
and to become the MacKee Professor. 
He reached the full flower of his aca-
demic potential during the almost 
quarter century of his tenure in that 
position.
Alas, during that time academic 
medicine changed and academic 
leaders faced new and different chal-
lenges. Research funding became 
more difficult, and funds from private 
and commercial sources became more 
important. As we both accepted senior 
positions in medicine in New York City 
— the heart of commercial and eco-
nomic America — our dealings with 
the shakers and movers were exten-
sive and necessary for the fulfillment 
of our missions. A small vignette to 
capture that time: I too was planning 
to leave a Harvard Medical School 
professorship for new opportunities 
in la Grande Pomme as the physician 
in chief at Memorial Sloan-Kettering 
Cancer Center. While considering and 
negotiating in New York, I stopped by 
to see Irwin and to ask about being a 
medical leader in that great city. He 
recollected that, in Boston, when we 
went to the symphony we saw many 
familiar faces, and being a professor 
in a medical school was a desired and 
respected position. This, he assured 
me, was also true in Baltimore. But 
things were different in New York. 
One rarely saw a familiar face at the 
opera or the symphony, and to those 
captains of industry, medical profes-
sors were not particularly important 
or respected. They were, however, 
collected and/or cultivated by these 
business leaders, primarily for possi-
ble medical advice and care for them-
selves and their families, colleagues, 
and employees. This was especially 
true for plastic surgeons.
Throughout the United States, 
medical-care concerns changed as 
well. Institutional competition, man-
aged care, and containment of health-
care costs made academic medical 
practice much more difficult; all this 
occurred at the same time as much 
greater competition for a limited grant 
pool. Parenthetically, it should be 
noted that throughout the vicissitudes 
of funding availability, remarkably, 
Irwin’s National Institutes of Health 
R01 grant “Epidermal Macromolecular 
Metabolism” received 40 years of con-
tinuous funding until 2001. Despite 
these challenges to medical leader-
ship, both Irwin and his wife, Irene, 
flourished in New York professionally 
and personally. They partook of much 
that that city has to offer with their 
usual vigor and enthusiasm. Opera, 
symphony, theater, temple, friends, 
and, of course, family all vied for 
their time and attention. This would 
appear to be a full life, but it was not 
sufficient for Irwin, for he had a spe-
cial feeling for New Hampshire. It 
was there, at Dartmouth, that he had 
received his undergraduate education, 
and Holderness is the site of the fam-
ily retreat. His joie de vivre was fully 
requited by the lakes and mountains, 
in summer and winter, boating and 
swimming in the former and skiing 
in the latter, all in the company of his 
family and friends.
Irwin was committed to academic 
medicine throughout his final illness; 
he continued to work as long as pos-
sible and was busy reviewing book 
galleys almost to the end. He was very 
concerned about the state of academ-
ic medicine in general and dermatol-
ogy in particular. He fretted about the 
increasing commercialism in both and 
the lure of procedural reimbursement 
affecting dermatology. At the same 
time, Irwin was excited about the 
great promise offered by the new biol-
ogy to greatly improve medical care. 
These concerns generally applied to 
all of academic medicine.
When we began our medical 
careers we seemed to have bound-
less energy, invigorated as we were 
by the new biology and the opportu-
nities it would offer to medicine. We 
had only limited concerns regarding 
health-care financing or the distribu-
tion of medical care. Collaboration 
rather than competition was the norm. 
In retrospect it seems that times were 
better then, but that is probably to 
be expected from those of us in our 
senior professional years when we 
look back at our youth. New opportu-
nities, hazards, and diversions require 
agile reaction and real commitment. 
This is the only effective response to 
these interesting times. Irwin pos-
sessed these characteristics in abun-
dance. From his great and enthusiastic 
capacity for work as a caring physi-
cian, scientist, and academic leader, 
to his joyous participation in skiing, 
swimming, boating, travel, and vari-
ous cultural activities, Irwin was a 
man for all seasons, both figuratively 
and literally. He was also a mensch.
